Medicine information NEXOBRID 2g powder and gel for gel

Product code:
W61476001
Quantity:
1
Indicated for:
wound debridement
Route of administration:
cutaneous
ATC
D03BA03 — Dermatologicals | Enzymes | Proteolytic enzymes
Proteolytic enzyme concentrate with bromelain is used for the treatment of inflammation and edema associated with trauma or surgical procedures. Bromelain, an enzyme extracted from pineapple, has anti-inflammatory properties and helps reduce swelling and pain.

This supplement is taken orally, usually in the form of tablets or capsules, with the dose adjusted based on the severity of the condition. Possible side effects include gastrointestinal disturbances, allergic reactions, and diarrhea.

Bromelain concentrate is contraindicated in patients with an allergy to pineapple or other active substances in the composition. It should also be used with caution in patients taking anticoagulants, as it may increase the risk of bleeding.

This product is a natural option for managing inflammation and edema, aiding in faster recovery after trauma or surgical procedures.

General data about NEXOBRID 2g

Substance:
bromelain proteolytic enzyme concentrate
Date of latest medicines list:
01-07-2020
Product code:
W61476001
Strength:
2g
Pharmaceutical form:
powder and gel for gel
Quantity:
1
Product type:
Original
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
HÄLSA PHARMA GMBH - GERMANIA
Holder:
MEDIWOUND GERMANY GMBH - GERMANIA
Number:
803/2012/01
Shelf life:
3 years

Strengths available for bromelain proteolytic enzyme concentrate

  • 2g
  • 5g

Official documents

The SmPC text is not displayed because a match to this medicine, strength and pharmaceutical form has not been confirmed.

The correspondence between the document and the displayed text is unconfirmed.

Source institution
EMA
Document language
English
Source record: first published
07/01/2013
Source record: last updated
03/12/2025